St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety

ST. CLOUD, Minn.--(BUSINESS WIRE)--Xenex Disinfection Services today announced that St. Cloud Surgical Center is the first ambulatory surgery center (ASC) in the U.S. and the first healthcare facility in St. Cloud to utilize a Xenex germ-zapping robot to enhance patient safety by destroying the deadly pathogens that can cause healthcare associated infections (HAI). St. Cloud Surgical Center is using Xenex’s full-spectrum UV disinfection system to disinfect its surgical suites daily.

 “We decided to use the Xenex robot because we want to provide patients with the highest level of safety and environmental cleanliness during surgical procedures at St. Cloud Surgical Center,” said Dr. Joseph P. Nessler, orthopedic surgeon and St. Cloud Surgical Center physician partner.

The Xenex pulsed xenon UV disinfection system is the fastest, safest and most effective method for the advanced cleaning of healthcare facilities, scientifically proven to reduce all major classes of microorganisms, including Clostridium difficile (C. diff), norovirus, influenza and Methicillin-resistant Staphylococcus aureus (MRSA). At St. Cloud Surgical Center, the easily portable robot is used in the surgical suites daily after terminal cleaning of the operating room (OR) has taken place. Taking only 5-10 minutes, the robot is utilized to disinfect rooms before and after total joint procedures, as well as after any procedure involving a patient known to have a dangerous infection.

“Patient safety is our top priority,” said Julie Tonsager, OR Team Leader at St. Cloud Surgical Center. “We clean the rooms with traditional cleaning methods, but there are always nooks and crannies that are hard to reach. And, the germs are getting tougher and so it was important for us to take the battle against infections to the next level to ensure our patients receive the best care -- and the Xenex robot allows us to do just that. We evaluated many different options for room disinfection and after careful analysis we chose the Xenex robot because of its proven results.”

The Xenex germ-zapping robot works by pulsing xenon, an inert gas, at high intensity in a xenon ultraviolet flashlamp. This produces broad spectrum ultraviolet C (UVC), which penetrates the cell walls of microorganisms. Their DNA is instantly fused so that they are unable to reproduce or mutate, effectively killing them on surfaces and in the air without contact or chemicals.

About St. Cloud Surgical Center
Founded in 1972, St. Cloud Surgical Center was the first freestanding outpatient surgical center in Minnesota and the second in the nation. An affiliate of Surgical Care Affiliates, St. Cloud Surgical Center offers high quality surgical services in a state-of-the-art surgical facility with 11 operating rooms. Accredited by the Accreditation Association for Ambulatory Health Care (AAAHC), St. Cloud Surgical Center serves patients across the state of Minnesota.

Source: http://www.businesswire.com
 

4 cheap small cap stocks I’ve got my eye for Christmas more

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

RBA to cut rates in 2015: Still want to invest in term deposits? more

Can robots help stop the Ebola outbreak? more

Robots Help Fight Ebola more

South Florida Hospital Unveils Ebola-Zapping Robot more

Sonoma Valley Hospital uses robot to kill germs more

Robots go to war against Ebola more

New iTraumaCare CEO to pursue big growth more

UAB and SRI have plans to spinoff more success more

Launch of Galderma's new acne products more

iTraumaCare’s new CEO to help company secure new funding more

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Robot fights germs at Sharp Chula Vista Medical Center more

Xenex updates protocols for germ-zapping robots in response to Ebola threat more

How do we get rid of the endotoxins? Birmingham's  has the solution more

Medical Device ® Positions New Leader for Next-Level Growth more

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Germ-zapping robot Gigi sets its sights on Ebola more

Morningside Ventures leads a Series B round for DNAtrix more

StemBioSys secures new research space at BioBridge Global more

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Company invents germ-zapping robot more

Xenex Congratulates Houston Cancer Hospital more

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Targeted Technology raises more than $40 million more

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Three Birmingham companies recognized in PwC report more

Former Kinetic Concepts Inc. CEO to lead StemBioSys more

International dermatology company Galderma confirmed more

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

San Antonio luring biotech firms with venture capital more

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

Milford hospital enlists robots in war against infections more

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more

TFS flags record full-year profit more

Sweet scented sandalwood flavour of month more

House committee looks for new technology in Veterans Affairs hospitals more

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

CEO shakeup at San Antonio biotech company StemBioSys more

First harvest to be completed in June more

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more

San Antonio biotech firm readies skin treatment for distribution more

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Medical technologies conference announces speaker lineup more

Australian sandalwood sells for millions more

Sandalwood exports as good as gold more

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

ViroXis Corporation Achieves Key Clinical Milestones more

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more